DataMeds AI, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
DataMeds AI, Inc. (MEDS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $23.16 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-20
- DataMeds AI, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $23.16M, a 1237.21% increase from fiscal 2024.
- DataMeds AI, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.73M, a 137.26% increase from fiscal 2023.
- DataMeds AI, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $730.14K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $23.16M 10-K · filed 2026-03-20 |
| 2024-12-31 | $1.73M 10-K · filed 2025-03-25 |
| 2023-12-31 | $730.14K 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |